Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Clive M. Kaye"'
Autor:
Clive M. Kaye, Briony Nicholls
Publikováno v:
Clinical Pharmacokinetics. 39:243-254
Ropinirole is a selective non-ergoline dopamine D2 receptor agonist indicated for use in treating Parkinson's disease. When taken as oral tablets, ropinirole is rapidly and almost completely absorbed, and it is extensively distributed from the vascul
Publikováno v:
The Journal of antimicrobial chemotherapy. 53
Amoxicillin/clavulanate (Augmentin ® ) is a broad-spectrum antibacterial that has been available for clinical use in a wide range of indications for over 20 years and is now used primarily in the treatment of community- acquired respiratory tract in
Autor:
Ann Allen, Clive M. Kaye, Nicholas Bird, Kevin SmithKline Beecham Pharmaceuticals Storm, Maria Davy, Odile Dewit, Sheryl Perry, Margaret McDonagh
Publikováno v:
Clinical therapeutics. 23(4)
Background: A new oral pharmacokinetically enhanced formulation of the broad-spectrum antibiotic amoxicillin/clavulanate has been developed to provide more effective therapy against resistant pathogens than is provided by currently available formulat
Publikováno v:
The Journal of Clinical Pharmacology. 14:363-368
Publikováno v:
Journal of Antimicrobial Chemotherapy. 18:213-219
A suspension of benzoylmetronidazole (6.4% w/v) was given orally at a dose of 15-25 ml, equivalent to 0.6-1 g metronidazole, once a day for three days to 11 children with giardiasis. Blood samples were collected after the first and third doses for an
Autor:
Clive M. Kaye
Publikováno v:
Biochemical Journal. 134:1093-1101
1. 3-Hydroxypropylmercapturic acid, i.e. N-acetyl-S-(3-hydroxypropyl)-l-cysteine, was isolated, as its dicyclohexylammonium salt, from the urine of rats after the subcutaneous injection of each of the following compounds: allyl alcohol, allyl formate
Autor:
Leslie Young, Clive M. Kaye
Publikováno v:
Biochemical Society Transactions. 2:308-310
Publikováno v:
American heart journal. 109(5 Pt 2)
During 10 years of clinical use involving almost 3 million patient-years acebutolol has become established as a remarkably safe and well-tolerated beta-blocking agent, effective in treating essential hypertension and cardiac arrhythmias. The existenc